Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
about
De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinomaInterventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapyNeoadjuvant chemotherapy in oral cancers: Selecting the right patientsRole of chemotherapy in nasopharyngeal carcinomaCombined-modality treatment improved outcome in sinonasal undifferentiated carcinoma: single-institutional experience of 21 patients and review of the literature.Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer.The efficacy of an induction chemotherapy combination with docetaxel, cisplatin, and 5-FU followed by concurrent chemoradiotherapy in advanced head and neck cancer.S-1 plus cisplatin: another option in the treatment of advanced head and neck cancer?Feasibility, toxicity, and efficacy of short induction chemotherapy of docetaxel plus cisplatin or carboplatin (TP) followed by concurrent chemoradio-therapy for organ preservation in advanced cancer of the hypopharynx, larynx, and base of tongue. ETriplet combination with paclitaxel, cisplatin and 5-FU is effective in metastatic and/or recurrent nasopharyngeal carcinoma.A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck.Sensitive HPV detection in oropharyngeal cancersInduction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.Phase II study of induction chemotherapy with TPF followed by radioimmunotherapy with Cetuximab and intensity-modulated radiotherapy (IMRT) in combination with a carbon ion boost for locally advanced tumours of the oro-, hypopharynx and larynx--TPF-[Multimodal laryngeal preservation: current data-based opinion].Docetaxel, cisplatin, and fluorouracil induction chemotherapy followed by accelerated fractionation/concomitant boost radiation and concurrent cisplatin in patients with advanced squamous cell head and neck cancer: A Southwest Oncology Group phase IA single centre experience with sequential and concomitant chemoradiotherapy in locally advanced stage IV tonsillar cancerCombination of taxanes, cisplatin and fluorouracil as induction chemotherapy for locally advanced head and neck cancer: a meta-analysis.The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer.Squamous cell carcinoma of the head and neck: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Induction chemotherapy with paclitaxel, ifosfamide, and cisplatin followed by concurrent chemoradiotherapy for unresectable locally advanced head and neck cancerImmunomodulated anterior chemotherapy followed by concurrent chemoradiotherapy in locally advanced tongue cancer: An Institutional experience.Nab-paclitaxel-based compared to docetaxel-based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neckInduction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective studyLactate dehydrogenase B is associated with the response to neoadjuvant chemotherapy in oral squamous cell carcinomaSequential therapy (triple drug-based induction chemotherapy followed by concurrent chemoradiotherapy) in locally advanced inoperable head and neck cancer patients - Single institute experience.Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III-IVB head and neck squamous cell carcinoma (HNSCC).Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: a meta-analysis.Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.The role of chemotherapy in the management of patients with head and neck cancer.A Phase II Study of Docetaxel, Cisplatin and 5- Fluorouracil (TPF) In Patients with Locally Advanced Head and Neck Carcinomas.Molecular analyses of unselected head and neck cancer cases demonstrates that human papillomavirus transcriptional activity is positively associated with survival and prognosis.Neoadjuvant chemotherapy and transoral surgery as a definitive treatment for oropharyngeal cancer: A feasible novel approach.Systemic therapy strategies for head-neck carcinomas: Current statusPropensity score matching analysis of cisplatin-based concurrent chemotherapy in low risk nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.A Phase II Clinical Trial of Concurrent Helical Tomotherapy plus Cetuximab Followed by Adjuvant Chemotherapy with Cisplatin and Docetaxel for Locally Advanced Nasopharyngeal Carcinoma.Combined modality treatment of laryngeal squamous cell carcinoma.Induction chemotherapy in head and neck squamous cell carcinoma of the paranasal sinus and nasal cavity: a role in organ preservationTen years of progress in head and neck cancers.
P2860
Q24200362-96FD8EAA-5FEF-4930-9F0C-3E5442ACEA45Q24235245-D9BFBF10-18E1-4421-A6C4-E4871F8DC1D2Q26768434-9D497345-2F6E-4B03-BCE1-778C28F5E6EBQ27022454-14BE27DF-6214-4D54-B47A-B6A2F793DC9AQ30422986-DF25CD17-DDE4-4821-8BC4-CFBA444888AEQ33380006-6AF15D70-9DF3-4776-B48B-7CA96969CC00Q33386187-6CF40B5E-D5EB-4C48-B42B-6F5C7DBB1549Q33389563-7D735A75-3CCD-4652-8968-E01848114464Q33393655-98813434-0A94-4F66-A87F-AC4677A03F3AQ33404307-8273F420-BC3B-41F3-B586-73C5C26096BDQ33491298-2EBA6A83-C749-4AAD-923A-B92ED7E53255Q33518034-2852C9B8-7EE4-4B2B-8609-EB4172D413DBQ33561959-D523651B-ED9D-4981-8538-2113CF6F48ACQ33906160-D2773F2B-50CB-4823-9C3E-BD9A99487B51Q34142639-B997AAA4-AAF1-4FEA-ADCE-D8A3C73613F1Q34257367-2C207A81-CDD0-46D5-BD11-55E669E105EBQ34498577-018BE181-4612-42F1-811E-9FD48673429AQ34511068-866756FA-7EC2-4341-9A6C-75CE0DCF306AQ34583677-6F6F3483-9E07-4401-8656-92AE5C99A372Q34620650-B429FB4B-41E0-4E3A-974F-C59BB908B2A8Q34991804-8B73D17C-710E-4EDB-AB0D-772AC751B034Q35188885-C8CA2AB4-AD3C-4AFE-918E-7CB34A116FF7Q35469234-CF32B4DB-0EBB-4093-9503-A69145F842CAQ35605411-329921C1-AA30-420B-BC0B-49BC4D8D1FC7Q35606525-A1D54EF8-B3AA-4B78-B71A-4F193FE69DBDQ35610879-081EE919-1011-436D-8557-6BF7D5C533BAQ35611873-2636A987-62E5-4D89-B60C-DC20FB721FFFQ35652246-D3D25EEE-7A48-40E3-9BCD-0568C3784F0CQ35694837-6D3671FB-C47A-4661-8C7D-8FB23C203E17Q35845864-BE92ECFA-8CE7-4F27-9FC7-E45E54F43B12Q35882999-81A24975-26C3-4B5D-A043-E2054E686397Q36022400-30C6060B-6457-4B5E-ABA8-54C2214854B7Q36050759-D3FEF2F7-109E-43B4-BC17-9837141ED4B4Q36051701-93EB24B7-B95C-4320-B916-8761CBF05CF6Q36529843-CE4A2E79-4BE3-4B88-AEEC-A5B402464E01Q36685556-EFBD4A50-1448-4E9A-896B-D02B16492E5DQ36727111-BDE52690-5C81-4532-A2D3-1925A9822419Q36752037-F39A2237-4699-48AE-91A1-4E208062C351Q36864470-BC8D7174-F194-413B-9FD6-E01DC9F2A3DCQ37002445-9EC99F66-DCA4-4D26-8650-4DED236D63D2
P2860
Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Phase III study comparing cisp ...... advanced head and neck cancer.
@en
Phase III study comparing cisp ...... advanced head and neck cancer.
@nl
type
label
Phase III study comparing cisp ...... advanced head and neck cancer.
@en
Phase III study comparing cisp ...... advanced head and neck cancer.
@nl
prefLabel
Phase III study comparing cisp ...... advanced head and neck cancer.
@en
Phase III study comparing cisp ...... advanced head and neck cancer.
@nl
P2093
P356
P1476
Phase III study comparing cisp ...... advanced head and neck cancer.
@en
P2093
Alfredo Rizo
Andrés Cervantes
Antonio Antón
Antonio López-Pousa
Carlos Chaib
Cinta Pallarés
Dolores Isla
Francisco Lobo
Hernán Cortés-Funes
Javier Martínez-Trufero
P304
P356
10.1200/JCO.2004.00.1990
P407
P577
2005-11-07T00:00:00Z